Homepage
Medication Guide
What Are the Indications for Erdafitinib (Balversa)?
Erdafitinib (Balversa) is an oral kinase inhibitor that was first approved in the United States in 2019. It represents a precision therapy option targeting specific genetic alterations, and is primari...
509
Wednesday, December 31st, 2025, 10:21
Dosage and Administration of Erdafitinib (Balversa)
Erdafitinib (Balversa) is a kinase inhibitor indicated for the treatment of adult patients with locally advanced or metastatic urothelial carcinoma harbouring susceptible FGFR3 or FGFR2 genetic altera...
514
Wednesday, December 31st, 2025, 10:03
What are the Precautions for Using Seladelpar?
Seladelpar is a novel peroxisome proliferator-activated receptor delta (PPAR-δ) agonist indicated for the treatment of adult patients with primary biliary cholangitis (PBC) who have an inadequate resp...
513
Tuesday, December 30th, 2025, 10:02
Adverse Reactions of Sladelpar
Sladelpar is a novel peroxisome proliferator-activated receptor delta (PPARδ) agonist. Approved in the United States in 2024, it is indicated for the treatment of adult patients with primary biliary c...
509
Tuesday, December 30th, 2025, 09:38
What Are the Purchase Channels for Voranidenib (Voranigo)?
Voranidenib (Voranigo) is a novel targeted therapy approved for marketing by the U.S. Food and Drug Administration (FDA) in 2024. It is indicated for the treatment of grade 2 gliomas (astrocytoma or o...
509
Tuesday, December 30th, 2025, 09:33
What are the Indications of Voranidenib (Voranigo)?
Voranidenib (Voranigo) is a novel oral targeted therapy, which was first approved for marketing in the United States in 2024. As a dual inhibitor of isocitrate dehydrogenase-1 (IDH1) and isocitrate de...
510
Tuesday, December 30th, 2025, 09:29
Dosage and Administration of Voranidenib (Voranigo)
Voranidenib (Voranigo) is an oral inhibitor of isocitrate dehydrogenase-1 (IDH1) and isocitrate dehydrogenase-2 (IDH2). It is indicated for the treatment of adult patients and pediatric patients aged ...
510
Tuesday, December 30th, 2025, 09:24
Adverse Reactions of Pretomanid
Pretomanid is an oral nitroimidazooxazine antimycobacterial agent indicated for the treatment of pulmonary tuberculosis (TB) in adults with extensively drug-resistant (XDR) or multidrug-resistant (MDR...
511
Monday, December 29th, 2025, 11:04
What are the Precautions for Pretomanid Administration?
Pretomanid is an oral nitroimidazooxazine antimycobacterial agent. As part of a combination therapeutic regimen with bedaquiline and linezolid, it is specifically indicated for the treatment of specif...
513
Monday, December 29th, 2025, 11:03
Where to Purchase Lazertinib
Lazertinib is an oral kinase inhibitor for combined use with Amivantamab, offering a novel treatment option for patients with advanced non-small cell lung cancer (NSCLC) harboring specific epidermal g...
505
Monday, December 29th, 2025, 10:33
35 / 221
2204 in total
Departments
Oncology Hematology Immunology Hepatology Endocrinology Pulmonology Neurology Cardiology Gastroenterology Dermatology
Contact Medical Consultant
Global Drug Search
Clinical recruitment
overseas medical treatment
Remote consultation
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Click to submit medical consultant
Contact Us
haiousales@gmail.com
Welcome To Consult
Seagull Pharmacy.,Ltd All rights reserved